Kuros was formed in in Zurich, Switzerland in 2000, as a spin-off from the Swiss Federal Institute of Technology (ETH) and University of Zurich.Kuros is a biotechnology company that develops novel biologics and biomaterial combinations for localised therapy.The company is focused on indications of high unmet medical need with initial programs in wounds, surgery, spine and trauma.